Maura Scarlattei
Via Gramsci 14
Parma, 43126, Italy
Parma, 43126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
The 68Ge/68Ga generator for enhancing productivity and reducing costs in nuclear medicine: experience from a university hospital.
Journal: EJNMMI radiopharmacy and chemistry
Published: February 03, 2026
State-of-the-art 32 cm field-of-view digital PET/CT system: preliminary study for protocols optimization and DRLs update.
Journal: Radiation protection dosimetry
Published: September 03, 2025
Emerging Radioligands as Tools to Track Multi-Organ Senescence.
Journal: Diagnostics (Basel, Switzerland)
Published: September 03, 2025
Establishment and validation of an alternative automated synthesis of [68Ga]Ga-DOTA-Siglec-9 in an independent laboratory for clinical use.
Journal: EJNMMI radiopharmacy and chemistry
Published: August 19, 2025
Iatrogenic cerebral amyloid angiopathy and cerebral amyloid angiopathy-related inflammation: clinical, radiological and biological findings from a case.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: July 22, 2025
Validation of a radiosynthesis method and a novel quality control system for [68 Ga]Ga-MAA: is TLC enough to assess radiopharmaceutical quality?
Journal: EJNMMI radiopharmacy and chemistry
Published: August 21, 2024
Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC.
Journal: Clinical lung cancer
Published: May 15, 2024
Predicting amyloid-PET status in a memory clinic: The role of the novel antero-posterior index and visual rating scales.
Journal: Journal of the neurological sciences
Published: September 18, 2023
High Prognostic Value of 68Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry.
Journal: Diagnostics (Basel, Switzerland)
Published: August 02, 2023
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: April 25, 2023
Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit.
Journal: Chinese clinical oncology
Published: February 14, 2023
Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression.
Journal: EJNMMI radiopharmacy and chemistry
Published: December 20, 2022
Last Updated: 09/26/2026